These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10760335)

  • 21. Lipid treatment goals achieved in patients treated with statin drugs in Norwegian general practice.
    Svilaas A; Risberg K; Thoresen M; Ose L
    Am J Cardiol; 2000 Dec; 86(11):1250-3, A6. PubMed ID: 11090801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statin therapy is associated with reduced restenosis rates after coronary stent implantation in carriers of the Pl(A2)allele of the platelet glycoprotein IIIa gene.
    Walter DH; Schächinger V; Elsner M; Mach S; Dimmeler S; Auch-Schwelk W; Zeiher AM
    Eur Heart J; 2001 Apr; 22(7):587-95. PubMed ID: 11259146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Local delivery of nadroparin for the prevention of neointimal hyperplasia following stent implantation: results of the IMPRESS trial. A multicentre, randomized, clinical, angiographic and intravascular ultrasound study.
    Meneveau N; Schiele F; Grollier G; Farah B; Lablanche JM; Khalifé K; Machecourt J; Danchin N; Wolf JE; Simpson M; Hak JB; Bassand JP
    Eur Heart J; 2000 Nov; 21(21):1767-75. PubMed ID: 11052841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Small stent size and intimal hyperplasia contribute to restenosis: a volumetric intravascular ultrasound analysis.
    Dussaillant GR; Mintz GS; Pichard AD; Kent KM; Satler LF; Popma JJ; Wong SC; Leon MB
    J Am Coll Cardiol; 1995 Sep; 26(3):720-4. PubMed ID: 7642865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A paclitaxel-eluting stent for the prevention of coronary restenosis.
    Park SJ; Shim WH; Ho DS; Raizner AE; Park SW; Hong MK; Lee CW; Choi D; Jang Y; Lam R; Weissman NJ; Mintz GS
    N Engl J Med; 2003 Apr; 348(16):1537-45. PubMed ID: 12700373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conversion to tacrolimus and atorvastatin in cyclosporine-treated heart transplant recipients with dyslipidemia refractory to fluvastatin.
    Skalicka B; Kubanek M; Malek I; Vymetalova Y; Hoskova L; Podzimkova M; Kautzner J
    J Heart Lung Transplant; 2009 Jun; 28(6):598-604. PubMed ID: 19481021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on to statin for effectiveness (EASE) trial.
    Pearson TA; Denke MA; McBride PE; Battisti WP; Brady WE; Palmisano J
    Mayo Clin Proc; 2005 May; 80(5):587-95. PubMed ID: 15887425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost effectiveness of statin therapy for the primary prevention of major coronary events in individuals with type 2 diabetes.
    Brandle M; Davidson MB; Schriger DL; Lorber B; Herman WH
    Diabetes Care; 2003 Jun; 26(6):1796-801. PubMed ID: 12766112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The PARAGON stent study: a randomized trial of a new martensitic nitinol stent versus the Palmaz-Schatz stent for treatment of complex native coronary arterial lesions.
    Holmes DR; Lansky A; Kuntz R; Bell MR; Buchbinder M; Fortuna R; O'Shaughnessy CD; Popma J
    Am J Cardiol; 2000 Nov; 86(10):1073-9. PubMed ID: 11074202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipid levels and low-density lipoprotein cholesterol goal attainment in diabetic patients: rosuvastatin compared with other statins in usual care.
    Harley CR; Gandhi SK; Heien H; McDonough K; Nelson SP
    Expert Opin Pharmacother; 2008 Apr; 9(5):669-76. PubMed ID: 18345946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Persistence and adherence to cholesterol lowering agents: evidence from Régie de l'Assurance Maladie du Québec data.
    Lachaine J; Rinfret S; Merikle EP; Tarride JE
    Am Heart J; 2006 Jul; 152(1):164-9. PubMed ID: 16824851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiographic predictors of recurrence of restenosis after Wiktor stent implantation in native coronary arteries.
    de Jaegere P; Serruys PW; Bertrand M; Wiegand V; Marquis JF; Vrolicx M; Piessens J; Valeix B; Kober G; Bonnier H
    Am J Cardiol; 1993 Jul; 72(2):165-70. PubMed ID: 8328378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An economic analysis of the Atorvastatin Comparative Cholesterol Efficacy and Safety Study (ACCESS).
    Smith DG; McBurney CR
    Pharmacoeconomics; 2003; 21 Suppl 1():13-23. PubMed ID: 12648031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of event-free survival after repeat intracoronary procedure for in-stent restenosis; study with angiographic and intravascular ultrasound imaging.
    Schiele F; Meneveau N; Seronde MF; Deforet MF; Gupta S; Bassand JP
    Eur Heart J; 2000 May; 21(9):754-62. PubMed ID: 10739731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atorvastatin: gold standard for prophylaxis of myocardial ischemia and stroke - comparison of the clinical benefit of statins on the basis of randomized controlled endpoint studies.
    Gresser U; Gathof BS
    Eur J Med Res; 2004 Jan; 9(1):1-17. PubMed ID: 14766335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coronary stenting or balloon angioplasty for chronic total coronary occlusions: the Taiwan experience (a single-center report).
    Fang CC; Jao YT; Chen Y; Wang SP
    Angiology; 2005; 56(5):525-37. PubMed ID: 16193191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Persistence and determinants of statin therapy among middle-aged patients free of cardiovascular disease.
    Perreault S; Blais L; Dragomir A; Bouchard MH; Lalonde L; Laurier C; Collin J
    Eur J Clin Pharmacol; 2005 Oct; 61(9):667-74. PubMed ID: 16151763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study.
    Mehilli J; Byrne RA; Tiroch K; Pinieck S; Schulz S; Kufner S; Massberg S; Laugwitz KL; Schömig A; Kastrati A;
    J Am Coll Cardiol; 2010 Jun; 55(24):2710-6. PubMed ID: 20226618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group.
    Grines CL; Cox DA; Stone GW; Garcia E; Mattos LA; Giambartolomei A; Brodie BR; Madonna O; Eijgelshoven M; Lansky AJ; O'Neill WW; Morice MC
    N Engl J Med; 1999 Dec; 341(26):1949-56. PubMed ID: 10607811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of focal in-stent restenosis with balloon angioplasty alone versus stenting: Short- and long-term results.
    Mehran R; Dangas G; Abizaid A; Lansky AJ; Mintz GS; Pichard AD; Satler LF; Kent KM; Waksman R; Stone GW; Leon MB
    Am Heart J; 2001 Apr; 141(4):610-4. PubMed ID: 11275928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.